Cargando…

Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling

BACKGROUND: Polo-like kinase 3 (PLK3) has been documented as a tumor suppressor in several types of malignancies. However, the role of PLK3 in colorectal cancer (CRC) progression and glucose metabolism remains to be known. METHODS: The expression of PLK3 in CRC tissues was determined by immunohistoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Baochi, Sun, Hongze, Zhao, Jingkun, Xu, Zhuoqing, Liu, Yuan, Feng, Hao, Peng, Zhihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815449/ https://www.ncbi.nlm.nih.gov/pubmed/31655629 http://dx.doi.org/10.1186/s13046-019-1418-2

Ejemplares similares

A positive feedback loop of β-catenin/CCR2 axis promotes regorafenib resistance in colorectal cancer
por: Ou, Baochi, et al.
Publicado: (2019)

USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway
por: Sun, Hongze, et al.
Publicado: (2019)

Hsp90 Promotes Kinase Evolution
por: Lachowiec, Jennifer, et al.
Publicado: (2015)

Roles of Polo-like kinase 3 in suppressing tumor angiogenesis
por: Xu, Dazhong, et al.
Publicado: (2012)

Polo-like kinase in trypanosomes: an odd member out of the Polo family
por: Kurasawa, Yasuhiro, et al.
Publicado: (2020)

CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer
por: Wang, Xinying, et al.
Publicado: (2016)

Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells
por: Kudryavtseva, Anna V., et al.
Publicado: (2016)

Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation
por: Jiao, Yisheng, et al.
Publicado: (2011)

Putting a bit into the polo-box domain of polo-like kinase 1
por: Park, Jung-Eun, et al.
Publicado: (2015)

Hsp90 Maintains the Stability and Function of the Tau Phosphorylating Kinase GSK3β
por: Dou, Fei, et al.
Publicado: (2007)

HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients
por: Li, Zhaobo, et al.
Publicado: (2017)

Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3
por: Fu, Jin, et al.
Publicado: (2012)

STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
por: Romeo, Maria Anele, et al.
Publicado: (2020)

An aquatic virus exploits the IL6-STAT3-HSP90 signaling axis to promote viral entry
por: Hou, Guoli, et al.
Publicado: (2023)

The balance of Polo-like kinase 1 in tumorigenesis
por: Lu, Lin-Yu, et al.
Publicado: (2009)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

Combining TRAIL with PI3 Kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling
por: Saturno, Grazia, et al.
Publicado: (2013)

Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells
por: Han, Ding-pei, et al.
Publicado: (2012)

HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells
por: Schoof, Nils, et al.
Publicado: (2009)

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
por: Nizami, Sohaib, et al.
Publicado: (2020)

Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors
por: Zhao, Xue Zhi, et al.
Publicado: (2019)

Analysis of Conformational Determinants Underlying HSP90-Kinase Interaction
por: Kancha, Rama Krishna, et al.
Publicado: (2013)

Evolution of kinase polypharmacology across HSP90 drug discovery
por: Antolin, Albert A., et al.
Publicado: (2021)

Correction: An aquatic virus exploits the IL6-STAT3-HSP90 signaling axis to promote viral entry
por: Hou, Guoli, et al.
Publicado: (2023)

USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer
por: Kosinsky, Robyn Laura, et al.
Publicado: (2019)

HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer
por: Pudova, Elena A., et al.
Publicado: (2018)

Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration
por: Varga, Attila, et al.
Publicado: (2023)

Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
por: Yun, Sang-Moon, et al.
Publicado: (2009)

A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
por: Abdelfatah, Sara, et al.
Publicado: (2018)

Polo-like kinase-1 in DNA damage response
por: Hyun, Sun-Yi, et al.
Publicado: (2014)

Polo-like kinase 1 as target for cancer therapy
por: Weiß, Lily, et al.
Publicado: (2012)

Playing POLO-like kinase in NRAS mutant melanoma
por: Chen, Hsin-Yi, et al.
Publicado: (2015)

Role for polo-like kinase 4 in mediation of cytokinesis
por: Press, Michael F., et al.
Publicado: (2019)

Polo-Like Kinase 2: From Principle to Practice
por: Zhang, Chuanyong, et al.
Publicado: (2022)

Polo-like kinase 1 promotes pulmonary hypertension
por: Chen, Rongrong, et al.
Publicado: (2023)

Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer
por: Lin, Chunhao, et al.
Publicado: (2019)

Histone acetyltransferase and Polo-like kinase 3 inhibitors prevent rat galactose-induced cataract
por: Kanada, Fumito, et al.
Publicado: (2019)

Glucose intake hampers PKA-regulated HSP90 chaperone activity
por: Chen, Yu-Chen, et al.
Publicado: (2018)

Hsp90 dependence of a kinase is determined by its conformational landscape
por: Luo, Qi, et al.
Publicado: (2017)

HSP-90/kinase complexes are stabilized by the large PPIase FKB-6
por: Sima, Siyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r1o0vffr7ucn4gv79kok65jduf